Definition of Virologic Response and the Type of Assay Used for Quantification of Viral Load May Influence the Proportion of Responders to Antiretroviral Therapy
- 1 May 2000
- journal article
- letter
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 24 (1) , 82-83
- https://doi.org/10.1097/00126334-200005010-00016
Abstract
An abstract is unavailable. This article is available as a PDF only.This publication has 7 references indexed in Scilit:
- Clinical Trials Using HIV-1 RNA-Based Primary Endpoints: Statistical Analysis and Potential BiasesJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Antiretroviral treatment in 1998The Lancet, 1998
- Comparison of the QUANTIPLEX HIV-1 RNA 2.0 Assay with the AMPLICOR HIV-1 MONITOR 1.0 Assay for Quantitation of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma of Patients Receiving Stavudine-Didanosine Combination TherapyJournal of Clinical Microbiology, 1998
- Discrepant responses to triple combination antiretroviral therapy in advanced HIV diseaseAIDS, 1998
- Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patientsAIDS, 1997
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997